Outcomes after placement of a SX-ELLA oesophageal stent for refractory variceal bleeding-A national multicentre study

Nikolaus Pfisterer, Florian Riedl, Thomas Pachofszky, Michael Gschwantler, Kurt König, Benjamin Schuster, Mattias Mandorfer, Irina Gessl, Constanze Illiasch, Eva-Maria Fuchs, Lukas Unger, Werner Dolak, Andreas Maieron, Ludwig Kramer, Christian Madl, Michael Trauner, Thomas Reiberger

Publikation: Beitrag in Fachzeitschrift (peer-reviewed)Artikel in Fachzeitschrift

29 Zitate (Scopus)


BACKGROUND: Current guidelines favour the use of bleeding stents over balloon tamponade (BT) for refractory variceal bleeding (VB) from oesophageal varices. However, data on the efficacy and safety of self-expandable metal SX-ELLA Danis stents (SEMS) are limited.

METHODS: Cirrhotic patients receiving SEMS for VB at four tertiary care centres were included in this retrospective multicentre study. Rates of failure-to-control bleeding (within 5 days) and bleeding-related mortality (6 weeks) were assessed.

RESULTS: SEMS controlled VB in 79.4% (27/34) of patients. In the rest of patients, other rescue treatments including endoscopic band ligation (EBL, n = 3), SEMS renewed (n = 2) or Linton (n = 2) were applied; however, VB was only controlled in one patient. Early rebleeding within six weeks occurred in 17.6% (6/34) patients. Median SEMS dwell time was three (IQR:6) days. Overall n = 13/34 (38.2%) patients died with SEMS in situ. After SEMS removal, rebleeding and bleeding-related death occurred in n = 7 (35%) and n = 5 (14.7%) patients respectively. Only 32.4% (10/34) patients did not experience any rebleeding within six weeks after SEMS removal. Bleeding-related mortality was 47.1% (n = 16/34) and the median survival after SEMS placement was 2.1 months. Notably, no patient received an early transjugular intrahepatic portosystemic shunt (TIPS). The most common adverse events were stent dislocations (n = 13; 38.2%), while ulcers/necrosis of the oesophageal mucosa was seen in only four (11.8%) patients.

CONCLUSION: SEMS controlled refractory VB in most patients. However, bleeding-related mortality remained high. While SEMS dislocations were frequent, ulcers/necrosis of the oesophagus was rare. Further studies should investigate whether the wider use of early TIPS reduces bleeding-related mortality after SEMS placement.

Seiten (von - bis)290-298
FachzeitschriftLiver International
PublikationsstatusVeröffentlicht - Feb. 2019


Untersuchen Sie die Forschungsthemen von „Outcomes after placement of a SX-ELLA oesophageal stent for refractory variceal bleeding-A national multicentre study“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren